Symbol
| ACAT2
| contributors: mct - updated : 31-08-2010
|
HGNC name
| acetyl-Coenzyme A acetyltransferase 2
|
HGNC id
| 94
|
Susceptibility
|
coronary artey disease risk and high plasma lipid levels |
Variant & Polymorphism
| polymorphisms associated with CAD risk and plasma lipid levels |
|
|
Candidate gene
Marker
Therapy target
| target for prevention and treatment of hypercholesterolemia and atherosclerosis | |
ACAT2-specific inhibitors may hold unexpected therapeutic potential to treat both atherosclerosis and non-alcoholic fatty liver disease (Alger 2010) |
| | |
| mice genetically lacking ACAT2 in both the intestine and the liver were dramatically protected against hepatic neutral lipid (TG and cholesteryl ester) accumulation, with the greatest differences occurring in situations where dietary cholesterol was elevated (Alger 2010) |